Actively Recruiting
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Led by Emory University · Updated on 2025-12-16
10
Participants Needed
2
Research Sites
100 weeks
Total Duration
On this page
Sponsors
E
Emory University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
CONDITIONS
Official Title
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or Female
- Candidate with skin lesions
- Signed study-specific informed consent prior to study entry
- 18 years old
You will not qualify if you...
- Prior surgery or radiotherapy to the area to be treated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Emory University Hospital Midtown
Atlanta, Georgia, United States, 30308
Actively Recruiting
2
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States, 30322
Actively Recruiting
Research Team
M
Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here